ストックスクリーナーアプリを入手
61.10
5.07%
-3.26
プレマーケット:
60.80
-0.30
-0.49%
前日終値:
$64.36
開ける：
$65.03
24時間の取引高:
643.08K
Relative Volume:
0.92
時価総額：
$2.31B
収益：
-
当期純損益:
$-91.00M
株価収益率:
-16.65
EPS:
-3.67
ネットキャッシュフロー:
$-74.38M
1週間 パフォーマンス:
-8.66%
1か月 パフォーマンス:
-25.17%
6か月 パフォーマンス:
+1.51%
1年 パフォーマンス:
+10.41%
1日の値動き範囲:
$60.92
$65.03
1週間の範囲:
$60.92
$68.19
52週間の値動き範囲:
$30.82
$99.50
Disc Medicine Inc Stock (IRON) Company Profile
名前
Disc Medicine Inc
セクター
電話
(617) 674-9274
住所
321 ARSENAL STREET, SUITE 101, WATERTOWN
Compare IRON vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
IRON
Disc Medicine Inc
|
61.10 | 2.43B | 0 | -91.00M | -74.38M | -3.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
477.89 | 120.48B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
787.50 | 81.05B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
749.56 | 46.33B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
327.30 | 42.26B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
299.02 | 32.87B | 5.36B | 287.73M | 924.18M | 2.5229 |
Disc Medicine Inc Stock (IRON) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-11-03 | 再開されました | Stifel | Buy |
| 2025-07-21 | 開始されました | Truist | Buy |
| 2025-07-03 | 再開されました | Morgan Stanley | Overweight |
| 2025-06-11 | 再開されました | Raymond James | Strong Buy |
| 2025-02-27 | 開始されました | TD Cowen | Buy |
| 2024-11-05 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2024-11-04 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2024-10-23 | 開始されました | Jefferies | Buy |
| 2024-10-16 | 開始されました | Scotiabank | Sector Outperform |
| 2024-08-22 | 開始されました | Wells Fargo | Overweight |
| 2024-04-01 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2023-12-19 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2023-06-09 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2023-06-07 | 開始されました | H.C. Wainwright | Buy |
| 2023-05-17 | 開始されました | Raymond James | Outperform |
| 2023-04-28 | 開始されました | Cantor Fitzgerald | Overweight |
| 2023-04-21 | 開始されました | Stifel | Buy |
| 2023-04-20 | 開始されました | Morgan Stanley | Overweight |
| 2023-03-23 | 開始されました | BMO Capital Markets | Outperform |
| 2023-02-28 | 開始されました | SVB Securities | Outperform |
すべてを表示
Disc Medicine Inc (IRON) 最新ニュース
Insider Sell: William Savage Sells Shares of Disc Medicine Inc (IRON) - GuruFocus
William Jacob Savage Sells 7,378 Shares of Disc Medicine (NASDAQ:IRON) Stock - MarketBeat
Disc Medicine Lands New $20 Million Investment as FDA Sets Up Potential Q4 Catalyst - AOL.com
Disc Medicine CFO Sells $720k Worth of Shares Amid FDA Rejection - AOL.com
IRON Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
IRON: Multiple late-stage programs advance toward pivotal data and regulatory milestones in 2024 - TradingView
Disc Medicine, Inc. (NASDAQ:IRON) Short Interest Update - MarketBeat
Disc Medicine, Inc. (IRON) Stock Analysis: A 50% Potential Upside In The Biotech Sector - DirectorsTalk Interviews
IRON (NASDAQ: IRON) proposed insider sales including 13,093-share 12/15/2025 sale - Stock Titan
Watertown biotech cuts 20% of staff after FDA rejects rare disease drug - The Business Journals
IRON: Wells Fargo Raises Price Target for Disc Medicine | IRON S - GuruFocus
Disc Medicine (NASDAQ:IRON) Price Target Raised to $79.00 - MarketBeat
Disc Medicine Refocuses On APOLLO Trial After FDA Letter For Bitopertin - Sahm
Disc Medicine (IRON) Is Up 8.6% After Wider 2025 Losses And New Shelf RegistrationWhat's Changed - Yahoo Finance
A Look At Disc Medicine (IRON) Valuation After Recent Share Price Swings - Sahm
Disc Medicine (IRON) Announces Restructuring Following FDA Setba - GuruFocus
Disc Medicine announces workforce reduction and restructuring plan By Investing.com - Investing.com Australia
Disc Medicine announces workforce reduction and restructuring plan - Investing.com Nigeria
Insider Sell: Jean Franchi Sells Shares of Disc Medicine Inc (IR - GuruFocus
Disc Medicine (NASDAQ:IRON) CFO Sells $24,378.18 in Stock - MarketBeat
Disc Medicine Implements Restructuring Following FDA Response - TipRanks
Disc Medicine's board approves restructuring plan - marketscreener.com
Disc Medicine (IRON) CFO sells 353 shares under 10b5-1 plan - Stock Titan
Disc Medicine (IRON) trims workforce 20% after FDA letter, books $2M charge - Stock Titan
Disc Medicine (NASDAQ:IRON) Price Target Lowered to $83.00 at Truist Financial - MarketBeat
JPMorgan Chase & Co. Sells 90,737 Shares of Disc Medicine, Inc. $IRON - MarketBeat
Decoding Disc Medicine Inc (IRON): A Strategic SWOT Insight - GuruFocus
Disc Medicine (NASDAQ:IRON) Releases Quarterly Earnings Results - MarketBeat
Disc Medicine: Strong Cash Runway and Bitopertin Upside Support Buy Rating Despite Regulatory Setbacks - TipRanks
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc.- IRON - PR Newswire
Disc Medicine, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Disc Medicine's 2025 Net Loss Widens - marketscreener.com
Disc Medicine Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - The Manila Times
Disc Medicine, Inc. SEC 10-K Report - TradingView
Disc Medicine Reports Fourth Quarter and Full Year 2025 Financial Results - TradingView
Disc Medicine's 2025 net loss smaller than estimates - TradingView
Disc Medicine (NASDAQ: IRON) faces FDA CRL as hematology pipeline advances - Stock Titan
Disc Medicine (NASDAQ: IRON) details 2025 loss, cash runway and FDA letter - Stock Titan
After FDA setback, Disc Medicine pushes rare blood drugs with $791M cash - Stock Titan
Disc Medicine Stock Is Swinging, but This Fund's New $52 Million Bet Shows Conviction - AOL.com
Jean Franchi sells 7,081 IRON shares under 10b5-1 (IRON) - Stock Titan
Disc Medicine Stock Is Swinging, but This Fund's New $52 Million Bet Shows Conviction - The Motley Fool
Disc Medicine’s RALLY-IBD Trial Puts a Spotlight on Anemia Relief in IBD Patients - TipRanks
Opinion | Who’s in Charge at the FDA? - WSJ
IRON SEC FilingsDisc Medicine Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Aug Shorts: Should I invest in Disc Medicine Inc before earningsPortfolio Value Summary & Free Community Consensus Stock Picks - baoquankhu1.vn
Disc Medicine, Inc. (IRON) Stock Analysis: A High-Risk, High-Reward Play with 61.59% Potential Upside - DirectorsTalk Interviews
Disc Medicine to Participate in Upcoming Investor Conferences - The Manila Times
Biotech Disc Medicine lines up four investor events in March - Stock Titan
Disc Medicine to Seek Traditional FDA Approval for Bitopertin After EPP CRL; APOLLO Data Due Q4 - MarketBeat
Disc Medicine to pursue traditional U.S. approval after FDA rejects new fast-track route - AOL.com
Disc Medicine Inc (IRON) 財務データ
収益
当期純利益
現金流量
EPS
0.11%
6.00%
大文字化:
|
ボリューム (24 時間):